Saadia A Basit1, Nikhil Mathews2, Mark E Kunik3. 1. Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd., Houston, TX 77030, United States; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1977 Butler Blvd., Houston, TX 77030, United States. Electronic address: saadia.basit@va.gov. 2. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1977 Butler Blvd., Houston, TX 77030, United States. Electronic address: Nikhil.Mathews@bcm.edu. 3. Michael E. DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd., Houston, TX 77030, United States; Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1977 Butler Blvd., Houston, TX 77030, United States; VA South Central Mental Illness Research, Education and Clinical Center (a virtual center), United States. Electronic address: mkunik@bcm.edu.
Abstract
OBJECTIVE: To conduct a systematic review to assess the evidence for telemedicine interventions for pharmacologic adherence in persons with depression, bipolar disorder, or schizophrenia. METHOD: We searched PubMed and PsycINFO in August 2018 without restrictions on years or language. We also searched tables of contents in 2 journals, meeting abstracts, reference lists from identified studies and review articles. The selection criteria required that articles be randomized controlled trials involving outpatient adults diagnosed with depression, bipolar disorder, or schizophrenia; that they involve telemedicine interventions; and that they include an outcome of medication adherence. Initially, 1 author identified relevant titles. Two authors independently reviewed the abstracts and titles. RESULTS: Of 512 articles identified through database searching, we identified 17 articles that we categorized by intensity of intervention and rated by quality of evidence. There were 3 low-, 3 medium- and 11 high-intensity interventions. The most common type of technology used was the phone. Efficacy for adherence was demonstrated by 9 studies. CONCLUSIONS: Telemedicine may improve medication adherence in patients with depression, bipolar disorder, or schizophrenia. Future studies are needed to better understand how technology can be tailored to different types of nonadherence.
OBJECTIVE: To conduct a systematic review to assess the evidence for telemedicine interventions for pharmacologic adherence in persons with depression, bipolar disorder, or schizophrenia. METHOD: We searched PubMed and PsycINFO in August 2018 without restrictions on years or language. We also searched tables of contents in 2 journals, meeting abstracts, reference lists from identified studies and review articles. The selection criteria required that articles be randomized controlled trials involving outpatient adults diagnosed with depression, bipolar disorder, or schizophrenia; that they involve telemedicine interventions; and that they include an outcome of medication adherence. Initially, 1 author identified relevant titles. Two authors independently reviewed the abstracts and titles. RESULTS: Of 512 articles identified through database searching, we identified 17 articles that we categorized by intensity of intervention and rated by quality of evidence. There were 3 low-, 3 medium- and 11 high-intensity interventions. The most common type of technology used was the phone. Efficacy for adherence was demonstrated by 9 studies. CONCLUSIONS: Telemedicine may improve medication adherence in patients with depression, bipolar disorder, or schizophrenia. Future studies are needed to better understand how technology can be tailored to different types of nonadherence.
Authors: Alex H Gifford; Thida Ong; Christopher Dowd; Aricca D Van Citters; Peter Scalia; Kathryn A Sabadosa; Gregory S Sawicki Journal: J Cyst Fibros Date: 2021-12 Impact factor: 5.482
Authors: Tristan J Philippe; Naureen Sikder; Anna Jackson; Maya E Koblanski; Eric Liow; Andreas Pilarinos; Krisztina Vasarhelyi Journal: JMIR Ment Health Date: 2022-05-12
Authors: Neal Rangu; Sumer G Frank-Pearce; Adam C Alexander; Emily T Hébert; Chaelin Ra; Darla E Kendzor; Michael S Businelle Journal: Front Hum Neurosci Date: 2022-07-28 Impact factor: 3.473
Authors: Sven Kernebeck; Theresa S Busse; Maximilian D Böttcher; Jürgen Weitz; Jan Ehlers; Ulrich Bork Journal: World J Gastroenterol Date: 2020-08-07 Impact factor: 5.742
Authors: Cynthia F Corbett; Elizabeth M Combs; Peyton S Chandarana; Isabel Stringfellow; Karen Worthy; Thien Nguyen; Pamela J Wright; Jason M O'Kane Journal: JMIR Form Res Date: 2021-07-13